Niclosamide in COVID-19

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

NCT04452474 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers

NCT04576312 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)

NCT04541485 ·Status: TERMINATED ·Phase: PHASE1

To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold

NCT03005067 ·Status: COMPLETED ·Phase: PHASE2

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

CSL324 in COVID-19

NCT04519424 ·Status: WITHDRAWN ·Phase: PHASE2

Safety Study of SLV213 for the Treatment of COVID-19.

NCT06146374 ·Status: TERMINATED ·Phase: PHASE1

Intranasal INNA-051 for Prevention of COVID-19 in Adults

NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

NCT04421508 ·Status: TERMINATED ·Phase: PHASE3

Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19)

NCT04565392 ·Status: WITHDRAWN ·Phase: PHASE4

Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19

NCT04527471 ·Status: COMPLETED ·Phase: PHASE2

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

NCT04379492 ·Status: WITHDRAWN ·Phase: PHASE2

A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19

NCT04558021 ·Status: UNKNOWN ·Phase: PHASE3

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

NCT04734873 ·Status: TERMINATED ·Phase: PHASE3

Bucillamine in Treatment of Patients With COVID-19

NCT04504734 ·Status: TERMINATED ·Phase: PHASE3

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

NCT04382586 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19

NCT04784897 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

NCT04582318 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Niclosamide for Mild to Moderate COVID-19

NCT04399356 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

NCT05596045 ·Status: WITHDRAWN ·Phase: PHASE1

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

NCT05677893 ·Status: COMPLETED ·Phase: PHASE1

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

NCT05603143 ·Status: TERMINATED ·Phase: PHASE3

Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19

NCT04424901 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19

NCT04805671 ·Status: TERMINATED ·Phase: PHASE2/PHASE3